Regarding antitumor effects, mTOR signaling pathway activation is associated with poor pathological features, such as poor differentiation and vascular invasion, as well as early recurrence and poor prognosis in HCC [90]. This evidence concerns the gene MTOR and hepatocellular carcinoma.